The Multiplex Biomarker Imaging Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The Multiplex Biomarker Imaging market saw an increase from $0.49 billion in 2024 to $0.54 billion in 2025, with a compound annual growth rate (CAGR) of 11.0%.
The Multiplex Biomarker Imaging market is projected to reach a size of $0.82 billion in 2029, growing at a compound annual growth rate (CAGR) of 10.8%.
Download Your Free Sample of the 2025 Multiplex Biomarker Imaging Market Report and Uncover Key Trends Now!The drivers in the multiplex biomarker imaging market are:
• High incidence rates of cancer
• Growing need for precise diagnostic tools
• Increase in the prevalence of chronic diseases
• Rising aging population and the shift towards personalized medicine
The multiplex biomarker imaging market covered in this report is segmented –
1) By Component Type: Instruments, Software, Services
2) By Imaging Techniques: Immuno Fluorescence (IF) Assay, Tissue Microarray (TMA) Assay, Immunohistochemistry (IHC) Assay, Fluorescent In The Situ Hybridization (FISH) Assay, Toponome Imaging System (TIS)
3) By Application: Drug Safety, Oncology Studies, Genetic Characterization Studies
4) By End User: Research Institutes Government And Private, Clinical Labs, Pharmaceutical And Biotechnology
The trends in the multiplex biomarker imaging market are:
• Technological advancements and innovations in imaging technologies are defining future trends.
• Advances in digital pathology are becoming a significant emerging trend.
• Developments in data analysis and imaging software are shaping the market.
• The integration of AI and machine learning with imaging technologies is a major upcoming trend.
The major players in the multiplex biomarker imaging market are:
• Merck KGaA
• Thermo Fisher Scientific Inc.
North America was the largest region in the multiplex biomarker imaging market in 2023